市场调查报告书
商品编码
1401910
到 2030 年非侵入式监测设备市场预测:按类型、适应症、最终用户和地区分類的全球分析Non Invasive Monitoring Device Market Forecasts to 2030 - Global Analysis By Type, By Indication, By End User and By Geography |
根据Stratistics MRC预测,2023年全球非侵入式监测设备市场规模将达44亿美元,预计2030年将达到91亿美元,预测期内复合年增长率为10.8%。
非侵入性监测设备是无需在身体上打孔即可收集生理资料的医疗设备。这些设备,例如血压计和脉搏血氧计,通常用于追踪生命征象。
据欧洲心臟网络称,心血管疾病 (CVD) 导致欧洲约 390 万人死亡,欧盟 (EU) 超过 180 万人死亡。此外,2016年中国农村和都市区CVD死亡人数分别占45.50%和43.16%。
慢性病盛行率上升
这些疾病的盛行率持续上升,增加了对高效、便捷的监测解决方案的需求。非侵入性设备提供了连续追踪生命征象的重要手段,无需侵入性操作,这与现代医学对早期检测和预防性护理的强调相一致。这一趋势将推动市场向前发展,并推动非侵入性监测设备的创新和技术进步,以满足不断变化的医疗保健形势和慢性疾病患者不断增长的需求。
初期成本高
开发、製造和部署先进技术通常需要大量投资。这种经济障碍可能会限制非侵入性监测设备的普及,特别是在预算有限的卫生系统中。成本因素已成为医疗保健组织的关键考虑因素,限制了他们投资先进监控解决方案的能力。解决此限制的措施包括策略定价模型、降低製造成本的合作以及努力使非侵入性监测设备对医疗保健提供者和患者来说在经济上可行。可以考虑倡导有利的报销政策。
政府努力促进医疗保健可近性
优先考虑改善卫生基础设施和可近性的政策和计划,特别是在发展中地区,将营造有利于采用非侵入性监测设备的环境。随着各国政府寻求改善公共卫生成果并减轻卫生系统的压力,支持远端病患监测和居家照护技术的趋势日益明显。这种与政府医疗保健政策的一致性不仅扩大了市场范围,而且还促进将非侵入性监测解决方案整合到更广泛的医疗保健框架中,从而改善整体患者照护和结果。
资料安全问题
由于这些设备收集和传输敏感的医疗资料,因此诈欺的存取和资料外洩的风险是医疗保健提供者和患者的主要担忧。患者资讯的洩漏会破坏对该技术的信任并阻碍普及。减轻这种威胁需要严格的加密协议、强大的网路安全措施并遵守隐私法规。在这个市场运作的公司必须优先考虑开发安全且合规的解决方案,医疗保健相关人员必须采取措施在不断发展的非侵入性监测领域保护病患资料。我们在实施过程中需要保持警惕。
COVID-19 的爆发对市场产生了积极影响。大流行期间对病患监测的日益关注以及对远端医疗解决方案的需求加速了非侵入性监测设备的采用。随着居家医疗和远端医疗医疗的重视以及医院就诊次数的减少,这些设备对于远端监测患者生命体征已变得至关重要。这次疫情凸显了早期检测和持续监测的重要性,推动了对非侵入性解决方案的需求,这些解决方案提供了一种有效且便捷的方法来追踪传统医疗环境之外的健康参数。
预计血压计将成为预测期内最大的市场
血压计占据了很大的占有率。随着全球高血压和心血管疾病盛行率不断上升,对准确、便利的血压监测解决方案的需求迅速增加。技术的进步促进了用户友好型便携式设备的发展,增加了它们在临床环境和家庭使用中的采用。数位功能、无线连接以及与行动健康应用程式的兼容性的整合使血压计对于非侵入性监测更具吸引力。
医院部门预计在预测期内复合年增长率最高
在预测期内,医院的复合年增长率最高。从生命征象监测仪到穿戴式健康追踪器,非侵入性监测设备为医院提供了一种有效的手段来持续追踪患者的健康状况,而无需进行侵入性手术。强调远端患者监护以及将非侵入性设备整合到医院工作流程中有助于改善患者照护、及时干预并简化医疗服务。随着医院优先考虑现代化和以患者为中心的护理,对非侵入性监测设备的需求持续增长并塑造医疗保健业务的未来。
北美占据重要地位,预计在预测期内将保持最大占有率。该地区先进的医疗基础设施和强大的研发能力推动了非侵入性监测技术的创新。预防保健医疗意识的提高和慢性病的高盛行率增加了对这些设备的需求。此外,政府的支持政策、人口高龄化的加剧以及先进医疗技术的采用也进一步推动了市场的发展。由于主要市场参与企业的存在和策略合作,北美在塑造非侵入式监控设备市场轨迹方面发挥主导作用。
由于医疗基础设施的扩张和对技术进步的日益重视,亚太地区的复合年增长率最高。该地区人口众多且多样化,加上医疗保健意识不断增强,正在推动对非侵入性监测解决方案的需求。亚太国家政府正在增加对医疗保健的投资,推动市场成长。慢性病的日益普及和向居家医疗的转变进一步推动了非侵入性设备的采用。因此,亚太地区正在成为非侵入性监测技术发展的关键贡献者和创新者。
According to Stratistics MRC, the Global Non Invasive Monitoring Device Market is accounted for $4.4 billion in 2023 and is expected to reach $9.1 billion by 2030 growing at a CAGR of 10.8% during the forecast period. A non-invasive monitoring device is a medical instrument that gathers physiological data without penetrating the body. These devices, such as blood pressure monitors or pulse oximeters, are commonly used to track vital signs.
According to the European Heart Network, Cardiovascular Diseases (CVDs) have been a cause of ~3.9 million deaths in Europe and more than 1.8 million deaths in the European Union (EU). Further, in China, CVDs led to 45.50% and 43.16% of total death in rural areas and urban areas, respectively, in 2016.
The rising prevalence of chronic diseases
The incidence of these conditions continues to rise, there is a growing demand for efficient and convenient monitoring solutions. Non-invasive devices provide a crucial means to continuously track vital signs without the need for invasive procedures, aligning with the contemporary healthcare emphasis on early detection and preventative care. This trend propels the market forward, fostering innovation and technological advancements in non-invasive monitoring devices to address the evolving healthcare landscape and the increasing needs of patients with chronic illnesses.
High initial costs
The development, manufacturing and implementation of sophisticated technologies often require substantial investments. This financial barrier can limit the widespread adoption of non-invasive monitoring devices, particularly in healthcare systems with constrained budgets. The cost factor becomes a crucial consideration for healthcare institutions, hindering their ability to invest in advanced monitoring solutions. Efforts to address this restraint may involve strategic pricing models, collaborations to reduce production costs, and advocacy for favorable reimbursement policies to make non-invasive monitoring devices more economically viable for both providers and patients.
Government initiatives to promote healthcare access
Policies and programs that prioritize enhanced healthcare infrastructure and accessibility, particularly in developing regions, foster a conducive environment for the adoption of non-invasive monitoring devices. As governments strive to improve public health outcomes and reduce the burden on healthcare systems, there is a growing inclination towards supporting technologies that enable remote patient monitoring and home-based care. This alignment with governmental healthcare agendas not only expands the market reach but also encourages the integration of non-invasive monitoring solutions into broader healthcare frameworks, enhancing overall patient care and outcomes.
Data security concerns
These devices collect and transmit sensitive health data, the risk of unauthorized access and data breaches is a major apprehension for both healthcare providers and patients. Instances of compromised patient information can erode trust in the technology and impede widespread adoption. Mitigating this threat requires stringent encryption protocols, robust cybersecurity measures, and adherence to privacy regulations. Companies operating in this market must prioritize the development of secure and compliant solutions, and healthcare stakeholders should stay vigilant in implementing measures to safeguard patient data in the evolving landscape of non-invasive monitoring.
The COVID-19 pandemic has positively impacted the market. The heightened focus on patient monitoring and the need for remote healthcare solutions during the pandemic accelerated the adoption of non-invasive monitoring devices. With an increased emphasis on home-based care and telemedicine to reduce hospital visits, these devices have become integral in monitoring patients' vital signs remotely. The pandemic underscored the importance of early detection and continuous monitoring, driving the demand for non-invasive solutions that provide effective and convenient ways to track health parameters outside traditional healthcare settings.
The blood pressure monitor is expected to be the largest during the forecast period
The blood pressure monitor has a significant share in the market. With a rising global prevalence of hypertension and cardiovascular diseases, the demand for accurate and convenient blood pressure monitoring solutions has surged. Technological advancements have led to the development of user-friendly and portable devices, contributing to increased adoption both in clinical settings and for home use. The integration of digital features, wireless connectivity, and compatibility with mobile health applications further enhances the appeal of blood pressure monitors in the non-invasive monitoring landscape.
The hospitals segment is expected to have the highest CAGR during the forecast period
The hospitals have the highest CAGR within the market over the forecast period. Non-invasive monitoring devices, ranging from vital sign monitors to wearable health trackers, offer hospitals efficient means to continuously track patients' health without invasive procedures. The emphasis on remote patient monitoring and the integration of non-invasive devices into hospital workflows contribute to improved patient care, timely interventions, and streamlined healthcare delivery. As hospitals prioritize modernization and patient-centric care, the demand for non-invasive monitoring devices continues to grow, shaping the future of healthcare practices.
North America holds a significant position and expected to hold a largest share over the forecast period. The region's advanced healthcare infrastructure, coupled with robust research and development activities, drives innovation in non-invasive monitoring technologies. Increasing awareness of preventive healthcare and a high prevalence of chronic diseases contribute to the demand for these devices. Additionally, supportive government policies, a growing aging population, and the adoption of advanced healthcare technologies further propel the market. The presence of key market players and strategic collaborations in North America solidify its leadership role in shaping the trajectory of the Non-Invasive Monitoring Device Market.
The Asia-Pacific region witnessed the highest CAGR in the market, driven by expanding healthcare infrastructure and a growing emphasis on technological advancements. The region's large and diverse population, coupled with rising healthcare awareness, fuels the demand for non-invasive monitoring solutions. Governments in several Asia Pacific countries are increasingly investing in healthcare, fostering market growth. The increasing prevalence of chronic diseases and a shift toward home healthcare further boost the adoption of non-invasive devices. As a result, Asia Pacific is emerging as a key contributor and innovator in the evolving landscape of non-invasive monitoring technologies.
Some of the key players in Non Invasive Monitoring Device Market include A&D Medical, Imacor, Abbott, Baxter, Koninklijke Philips N.V., CAS Medical Systems, Conmed Corporation, Deltex Medical Limited, General Electric, Medtronic, Vaso Corporation and Omron.
In October 2023, Baxter International Inc. (NYSE:BAX) announced the launch of digital image capture capability for eye exams using its existing Welch Allyn PanOptic Plus Ophthalmoscope.
In October 2023, Royal Philips a global leader in health technology announced it has received a second round of funding from the Bill & Melinda Gates Foundation to accelerate global adoption of AI algorithms on Philips Lumify Handheld Ultrasound.